Table 3.
Univariable and multivariable analyses of predictors of DMFS and OS for propensity score-matched cohort in p-stage I-III patients
| Variable | Univariable analysis of DMFS | Univariable analysis of OS | |||||
|---|---|---|---|---|---|---|---|
| HR | 95%CI | p value | HR | 95%CI | p value | ||
| Age(≥60 v <60) | 1.478 | 1.016-2.150 | 0.041** | 1.569 | 1.031-2.387 | 0.036** | |
| Gender (female v male) | 0.867 | 0.595-1.263 | 0.458 | 0.709 | 0.464-1.086 | 0.114 | |
| T stage | 1.329 | 1.024-1.726 | 0.033* | 1.280 | 0.952-1.721 | 0.103 | |
| N stage | 1.636 | 1.334-2.008 | <0.001** | 1.754 | 1.395-2.205 | <0.001** | |
| Location (Peripheral v Central) | 0.675 | 0.391-1.165 | 0.158 | 0.589 | 0.332-1.044 | 0.070 | |
| Pathology | |||||||
| Scc v Ad | 0.558 | 0.314-0.991 | 0.046** | 0.654 | 0.333-1.283 | 0.216 | |
| Others v Ad | 0.660 | 0.344-1.264 | 0.210 | 0.886 | 0.421-1.863 | 0.750 | |
| Chemotherapy# | 0.859 | 0.590-1.250 | 0.428 | 0.584 | 0.382-0.892 | 0.013** | |
| CTNB or non-biopsy | 1.323 | 0.909-1.927 | 0.144 | 1.388 | 0.911-2.114 | 0.127 | |
| Radiotherapy# | 1.231 | 0.502-3.022 | 0.650 | 1.526 | 0.619-3.764 | 0.359 | |
Abbreviations: CTNB, computed tomography-guided needle biopsy; Ad, adenocarcinoma; Scc: squamous-cell carcinoma; HR, hazard ratio; CI, confidence interval. *variables were Statistical significance in univariable analysis; **variables were also Statistical significance in multivariable analysis. #: adjuvant therapy.